- Home
- MTEK vs INDP Comparison
MTEK vs INDP Comparison
Compare MTEK & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- INDP
- Stock Information
- Founded
- MTEK 2008
- INDP 2000
- Country
- MTEK Israel
- INDP United States
- Employees
- MTEK N/A
- INDP N/A
- Industry
- MTEK
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- INDP Health Care
- Exchange
- MTEK Nasdaq
- INDP Nasdaq
- Market Cap
- MTEK 17.6M
- INDP 10.2M
- IPO Year
- MTEK 2022
- INDP N/A
- Fundamental
- Price
- MTEK $5.52
- INDP $0.88
- Analyst Decision
- MTEK
- INDP Strong Buy
- Analyst Count
- MTEK 0
- INDP 2
- Target Price
- MTEK N/A
- INDP $8.50
- AVG Volume (30 Days)
- MTEK 388.2K
- INDP 22.1K
- Earning Date
- MTEK 01-07-2025
- INDP 11-12-2024
- Dividend Yield
- MTEK N/A
- INDP N/A
- EPS Growth
- MTEK N/A
- INDP N/A
- EPS
- MTEK N/A
- INDP N/A
- Revenue
- MTEK $6,967,508.00
- INDP N/A
- Revenue This Year
- MTEK N/A
- INDP N/A
- Revenue Next Year
- MTEK N/A
- INDP N/A
- P/E Ratio
- MTEK N/A
- INDP N/A
- Revenue Growth
- MTEK 246.50
- INDP N/A
- 52 Week Low
- MTEK $1.02
- INDP $0.81
- 52 Week High
- MTEK $5.40
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- MTEK 70.37
- INDP 33.67
- Support Level
- MTEK $4.61
- INDP $0.81
- Resistance Level
- MTEK $5.40
- INDP $1.01
- Average True Range (ATR)
- MTEK 0.70
- INDP 0.06
- MACD
- MTEK 0.12
- INDP -0.00
- Stochastic Oscillator
- MTEK 76.83
- INDP 11.77
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.